Pretty sure the FDA feedback you're referring to is what was announced re dosage. The question of whether the trial should continue was part of that review and part of the announcement.
potentially important times, page-3
-
- There are more pages in this discussion • 39 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)